Klinik und Poliklinik für Geburtshilfe und Frauengesundheit
Klinikum / Johannes Gutenberg-Universität Mainz
Battista, M; Stickeler, E; Schmidt, M
Prädiktive Faktoren in der metastasierten SituationDer Gynäkologe. Bd. 48. 2015 S. 885-890
Albrich, S.; Rommens, K.; Steetskamp, J. et al.
Prevalence of Levator Ani Defects in Urogynecological PatientsGEBURTSHILFE UND FRAUENHEILKUNDE. Bd. 75. H. 1. 2015 S. 51-55
Schmidt, Marcus; van de Sandt, Leonie; Almstedt, Katrin et al.
Prognostic significance of Focal Adhesion Kinase (FAK) in node-negative breast cancer.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Schmidt, Marcus; van de Sandt, Leonie; Edlund, Karolina et al.
Prognostic significance of the interferon metagene in node-negative breast cancer depends on the molecular subtypeCANCER RESEARCH. Bd. 75. H. 9. 2015
Liedtke, C; Schmidt, M
Prognostische und Prädiktive Faktoren beim Mammakarzinom - welche Biomarker sind wichtig?Klinikarzt. Bd. 44. H. 2. 2015 S. 90-95
Almstedt, Katrin; Schmidt, Marcus
Targeted Therapies Overcoming Endocrine Resistance in Hormone Receptor-Positive Breast CancerBREAST CARE. Bd. 10. H. 3. 2015 S. 168-172
Finn, Richard S.; Crown, John P.; Lang, Istvan et al.
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 studyLANCET ONCOLOGY. Bd. 16. H. 1. 2015 S. 25-35
Finn, Richard S.; Crown, John; Lang, Istvan et al.
The effect of palbociclib (P) in combination with letrozole (L) on bone metastases in women with ER+/HER2-metastatic breast cancer (MBC): Subanalysis from a randomized phase II study.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Eichbaum, Michael Hans Robert; Schmidt, Marcus; Grischke, Eva-Maria et al.
The PACOVAR-trial: A multicenter phase I trial of pazopanib (GW786034) and metronomic cyclophosphamide in patients with recurrent platinum-resistant ovarian cancer.JOURNAL OF CLINICAL ONCOLOGY. Bd. 33. H. 15. 2015
Thaler, Sonja; Thiede, Gitta; Hengstler, Jan G. et al.
The proteasome inhibitor Bortezomib (Velcade) as potential inhibitor of estrogen receptor-positive breast cancerINTERNATIONAL JOURNAL OF CANCER. Bd. 137. H. 3. 2015 S. 686-697